| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Context Therapeutics Inc. Common Stock (NASDAQ: CNTX)
CNTX Technical Analysis
5
| As on 9th Jun 2023 CNTX STOCK Price closed @ 1.23 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.86 & Strong Sell for SHORT-TERM with Stoploss of 2.30 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CNTXSTOCK Price
| Open | 1.31 | Change | Price | % |
| High | 1.31 | 1 Day | -0.08 | -6.11 |
| Low | 1.18 | 1 Week | 0.35 | 39.77 |
| Close | 1.23 | 1 Month | 0.65 | 112.07 |
| Volume | 143660 | 1 Year | -1.74 | -58.59 |
| 52 Week High 3.24 | 52 Week Low 0.48 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| CNTX Daily Charts |
CNTX Intraday Charts |
Whats New @ Bazaartrend |
CNTX Free Analysis |
|
|
CNTX Important Levels Intraday
| RESISTANCE | 1.48 |
| RESISTANCE | 1.40 |
| RESISTANCE | 1.35 |
| RESISTANCE | 1.30 |
| SUPPORT | 1.16 |
| SUPPORT | 1.11 |
| SUPPORT | 1.06 |
| SUPPORT | 0.98 |
CNTX Forecast April 2024
| 4th UP Forecast | 3.08 |
| 3rd UP Forecast | 2.49 |
| 2nd UP Forecast | 2.12 |
| 1st UP Forecast | 1.75 |
| 1st DOWN Forecast | 0.71 |
| 2nd DOWN Forecast | 0.34 |
| 3rd DOWN Forecast | -0.03 |
| 4th DOWN Forecast | -0.62 |
CNTX Weekly Forecast
| 4th UP Forecast | 3.02 |
| 3rd UP Forecast | 2.45 |
| 2nd UP Forecast | 2.09 |
| 1st UP Forecast | 1.74 |
| 1st DOWN Forecast | 0.72 |
| 2nd DOWN Forecast | 0.37 |
| 3rd DOWN Forecast | 0.01 |
| 4th DOWN Forecast | -0.56 |
CNTX Forecast2024
| 4th UP Forecast | 7.05 |
| 3rd UP Forecast | 5.18 |
| 2nd UP Forecast | 4.03 |
| 1st UP Forecast | 2.88 |
| 1st DOWN Forecast | -0.42 |
| 2nd DOWN Forecast | -1.57 |
| 3rd DOWN Forecast | -2.72 |
| 4th DOWN Forecast | -4.59 |
Context Therapeutics Inc. Common Stock ( NASDAQ USA Symbol : CNTX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CNTX Business Profile
Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a selective potent antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therapeutics, such as ovarian, uterine (endometrial), and breast cancers. The company also engages in developing CLDN6xCD3 bsAb, an anti-CD3 x anti-Claudin 6 antigen bispecific monoclonal antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. In addition, it is involved in the development of Sigma1, a cellular protein that regulates homeostasis, which is in clinical studies for the treatment of breast and prostate cancer. Context Therapeutics Inc. has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of CLDN6xCD3 bsAb. The company was founded in 2015 and is based in Philadelphia, Pennsylvania. Address: 3675 Market Street, Philadelphia, PA, United States, 19104
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service